Improving Patient Outcomes with Individualized
Therapy in the Management of Type 2 Diabetes

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session at the 2016 Fall Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 1, 2017 to December 31, 2017

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.  To print or save your certificate, you will need to click on the “download” button and either print or save

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by educational grants from
Boehringer Ingelheim/Lilly USA, LLC, Novo Nordisk, and Sanofi US

Description:
The management of type 2 DM remains a major challenge as many patients continue to struggle with achieving therapeutic goals, including control of A1C level, blood pressure, cholesterol, and weight. Fortunately, recent advances in treatments in Type 2 Diabetes management have given healthcare professionals the ability to shrink this clinical practice gap. Fortunately, recent advances in individualizing treatment through basal insulin therapy and GLP-1 analogs in Type 2 Diabetes management have given healthcare professionals the ability to shrink this clinical practice gap, particularly when they are combined. This session will review novel treatments and identify which patients are most likely to benefit from their use, which will help them achieve tighter glucose control and better clinical outcomes.

Upon Completion of this activity, participants will be able to:

  • Evaluate the safety, efficacy and mechanisms of action of current and emerging therapies, including basal insulin and GLP-1 therapies, for achieving individualized target goals in types 2 diabetes (T2DM)

  • Examine emerging data related to combination of basal insulin and GLP-1 therapies and their potential place in the treatment of patients with type 2 diabetes

  • Discuss current treatment guidelines and identify which patients may benefit from basal insulin or GLP-1 therapy and when it should be initiated

  • Analyze new basal insulin or GLP-1 therapies for patients with T2DM, based on each patient’s individual profile, and how to intensify treatment if glycemic goals are not met

  • Identify barriers to effective and timely basal insulin or GLP-1 therapy use and implement strategies to overcome these barriers in T2DM management
     

Faculty: Timothy S. Reid, MD
Medical Director, Diabetes Center
Mercy Health System

Disclosure:

Dr. Reid receives speaker/consulting fees from Janssen, Lilly, Novo Nordisk and sanofi. His presentation has been peer reviewed.
 
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jacquelyn Smith, RN, BSN, MA, CMCN has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.
Will Williams has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

The National Association of Managed Care Physicians designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity and turn in a validation form will receive up to 1 credit in continuing nursing education.

The American Board of Managed Care Nurses has approved this activity for a maximum of 1 contact hour towards CMCN recertification.

This presentation is supported by educational grants from
Boehringer Ingelheim/Lilly USA, LLC, Novo Nordisk, and Sanofi US
Description

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue